project id: TCGA-HNSC; case submitter id: TCGA-F7-A623; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.65; rna integrity number: 9.3; age at index: 70; days to birth: -25592; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 25592; ajcc clinical m: MX; ajcc clinical n: NX; ajcc clinical t: TX; ajcc pathologic m: M0; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 616.0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Yes; cigarettes per day: 2.3013698630136985; pack years smoked: 42.0; is ffpe: false; composition: Not Reported; days to collection: 101; days to sample procurement: 0; initial weight: 800.0; portion submitter id: TCGA-F7-A623-01A-11; percent lymphocyte infiltration: 7.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;